Jones Financial Companies
CABA icon

Jones Financial Companies’s Cabaletta Bio CABA Stock Holding History

Jones Financial Companies’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.75K Sell
653
-20,007
-97% -$55.6K ﹤0.01% 4186
2025
Q4 		$45.2K Buy
20,660
+653
+3% +$1.62K ﹤0.01% 2574
2025
Q3 		$47.2K Buy
+20,007
New +$34.3K ﹤0.01% 2405
2025
Q2 		– Sell
-18,507
Closed -$28.7K – 4046
2025
Q1 		$28.7K Buy
18,507
+14,897
+413% +$31.7K ﹤0.01% 2291
2024
Q4 		$8.2K Buy
+3,610
New +$12.7K ﹤0.01% 2596

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Jones Financial Companies's CABA Position: Q1 2026 in Review

Jones Financial Companies reduced its Cabaletta Bio (CABA) stake by 97% in Q1 2026, selling an estimated $55.6K and leaving 653 shares worth $1.75K. The position accounts for ﹤0.01% of the portfolio, ranked #4186.

Jones Financial Companies first reported a position in CABA in Q4 2024 and has held it in 5 quarters since. The position peaked at $47.2K in Q3 2025. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

  • Jones Financial Companies held 653 shares of Cabaletta Bio worth $1.75K as of Q1 2026.
  • Jones Financial Companies sold 20,007 Cabaletta Bio shares in Q1 2026, an estimated $55.6K.
  • Cabaletta Bio made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4186 holding.
  • Jones Financial Companies first reported a position in Cabaletta Bio in Q4 2024 and has held it in 5 quarters since.
  • Jones Financial Companies's Cabaletta Bio position peaked at $47.2K in Q3 2025.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.